mRNA |
foretinib |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
LBW242 |
CCLE |
pan-cancer |
AAC |
0.026 |
0.6 |
mRNA |
BRD-K09344309 |
CTRPv2 |
pan-cancer |
AAC |
-0.041 |
0.6 |
mRNA |
MI-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.6 |
mRNA |
azacitidine |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
Compound 23 citrate |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
NSC632839 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.6 |